Pages that link to "Q37208100"

The following pages link to Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. (Q37208100):

Displaying 43 items.

• Atrial fibrillation: effects beyond the atrium? (Q26864877) (← links)
• EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. (Q30375302) (← links)
• Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation (Q30819519) (← links)
• Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis (Q33794241) (← links)
• Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease. (Q33846316) (← links)
• High molecular mass proteomics analyses of left ventricle from rats subjected to differential swimming training (Q34403884) (← links)
• Multiple biomarkers and atrial fibrillation in the general population (Q34525092) (← links)
• Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities (Q36108848) (← links)
• The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury (Q36260872) (← links)
• Sum of effects of myocardial ischemia followed by electrically induced tachycardia on myocardial function (Q36954716) (← links)
• Chronic heart failure and the substrate for atrial fibrillation. (Q37385641) (← links)
• Impaired Erythrocyte Deformability in Patients with Coronary Risk Factors: Significance of Nonvalvular Atrial Fibrillation (Q37495734) (← links)
• The Relationship Between Pericardial Fat and Atrial Fibrillation (Q37495937) (← links)
• The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications (Q37799958) (← links)
• Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation (Q37812402) (← links)
• The pharmaceutical pipeline for atrial fibrillation (Q37821928) (← links)
• Novel molecular targets for atrial fibrillation therapy (Q37998312) (← links)
• Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation. (Q38025390) (← links)
• Oxidative stress-mediated effects of angiotensin II in the cardiovascular system (Q38192646) (← links)
• Alterations in atrial perfusion during atrial fibrillation. (Q38234147) (← links)
• Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation (Q38377313) (← links)
• Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation (Q38703115) (← links)
• Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction (Q39193717) (← links)
• Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs (Q39439506) (← links)
• AFNET. A translational research network develops into an academic research organization (Q40852337) (← links)
• Human electronegative low-density lipoprotein modulates cardiac repolarization via LOX-1-mediated alteration of sarcolemmal ion channels. (Q41542147) (← links)
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (Q42923039) (← links)
• Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure (Q42959488) (← links)
• Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling (Q43138277) (← links)
• EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (Q45939560) (← links)
• Pleiotropic actions of amiodarone: still puzzling after half a century (Q46907800) (← links)
• Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoam (Q47775639) (← links)
• Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (Q47883450) (← links)
• Biomarkers of Cardiac Stress and Injury in Athletes: What Do They Mean? (Q52362155) (← links)
• Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation. (Q53318291) (← links)
• PPAR-γ activation limits angiotensin II-mediated atrial remodeling: one drug fits all AF patients? (Q54468788) (← links)
• EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. (Q55638585) (← links)
• Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction (Q58121759) (← links)
• Biomarkers of Atrial Fibrillation: Which One Is a True Marker? (Q64090263) (← links)
• The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation (Q83564394) (← links)
• Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis (Q86476754) (← links)
• Prognostic implications of troponin I elevation in emergency department patients with tachyarrhythmia (Q92517852) (← links)
• Effect of sepsis on the action potential and cardiac serotonin response in rats (Q92889801) (← links)